The Discussion of Peritoneal Dialysis Patients Taking Proper Portion of Valacyclovir  

作　　者：Wan-shan Chiang Charn-ting Wang Wei-Chih Kan Hui-Chen Huang 

机构地区：[1]Hemodialysis Center, Chi Mei Medical Center, Tainan, Taiwan, and Chiayi Nursing Research Institute, Chang Gung University of Science and Technology, Tainan 70960, Taiwan [2]Peritoneal Dialysis Center, Chi Mei Medical Center, Tainan 70960, Taiwan [3]Department of Nephrology, Chi-Mei Medical Center, Tainan, Taiwan and Department of Biological Science and Technology, ChungHwa University of Medical, Tainan 70960, Taiwan [4]Hemodialysis Center, Chi Mei Medical Center, Tainan 70960, Taiwan

出　　处：《Journal of Pharmacy and Pharmacology》2018年第4期425-428,共4页药剂与药理学（英文版）

摘　　要：Dialysis patients have risk in Zoster virus because of low immune. Valacyclovir, used for Zoster virus, is digested in kidney and it has side effect of nerve virus on patients with malfimction kidneys. This article reviews 8 dialysis cases and discusses the proper Valacyclovir portion for peritoneal dialysis patients.

关 键 词：Herpes zoster VALACYCLOVIR peritoneal dialysis health education. 

分 类 号：TS974.1[轻工技术与工程] TQ028.8[化学工程]